PDS Biotechnology Corporation (PDSB) DCF Valuation

PDS Biotechnology Corporation (PDSB) DCF Valuation
  • Totalmente Editável: Adapte-Se Às Suas Necessidades No Excel Ou Planilhas
  • Design Profissional: Modelos Confiáveis ​​E Padrão Da Indústria
  • Pré-Construídos Para Uso Rápido E Eficiente
  • Não É Necessária Experiência; Fácil De Seguir

PDS Biotechnology Corporation (PDSB) Bundle

DCF model
Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Designed for accuracy, our PDSB DCF Calculator allows you to evaluate the valuation of PDS Biotechnology Corporation using real-world financial data, providing complete flexibility to modify all key parameters for enhanced projections.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019
AY2
2020
AY3
2021
AY4
2022
AY5
2023
FY1
2024
FY2
2025
FY3
2026
FY4
2027
FY5
2028
Revenue .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Revenue Growth, % 0 0 0 0 0 0 0 0 0 0
EBITDA -7.2 -14.7 -21.2 -41.6 -40.1 .0 .0 .0 .0 .0
EBITDA, % 100 100 100 100 100 100 100 100 100 100
Depreciation .1 .2 .2 .0 .1 .0 .0 .0 .0 .0
Depreciation, % 100 100 100 100 100 100 100 100 100 100
EBIT -7.3 -14.8 -21.4 -41.7 -40.1 .0 .0 .0 .0 .0
EBIT, % 100 100 100 100 100 100 100 100 100 100
Total Cash 12.2 28.8 65.2 73.8 56.6 .0 .0 .0 .0 .0
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables .0 .0 .0 .0 .0
Account Receivables, % 100 100 100 100 100
Inventories .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Inventories, % 100 100 100 100 100 100 100 100 100 100
Accounts Payable 1.2 1.4 1.3 1.2 7.0 .0 .0 .0 .0 .0
Accounts Payable, % 100 100 100 100 100 100 100 100 100 100
Capital Expenditure .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Capital Expenditure, % 100 100 100 100 100 0 0 0 0 0
Tax Rate, % 3.17 3.17 3.17 3.17 3.17 3.17 3.17 3.17 3.17 3.17
EBITAT -7.0 -14.8 -16.9 -40.5 -38.9 .0 .0 .0 .0 .0
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -5.7 -14.5 -16.8 -40.5 -33.0 -7.0 .0 .0 .0 .0
WACC, % 14.54 14.83 13.67 14.67 14.65 14.47 14.47 14.47 14.47 14.47
PV UFCF
SUM PV UFCF -6.1
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) 0
Terminal Value 0
Present Terminal Value 0
Enterprise Value -6
Net Debt -33
Equity Value 27
Diluted Shares Outstanding, MM 31
Equity Value Per Share 0.86

What You Will Get

  • Real PDSB Financial Data: Pre-filled with PDS Biotechnology Corporation’s historical and projected data for precise analysis.
  • Fully Editable Template: Modify key inputs like revenue growth, WACC, and EBITDA % with ease.
  • Automatic Calculations: See PDSB’s intrinsic value update instantly based on your changes.
  • Professional Valuation Tool: Designed for investors, analysts, and consultants seeking accurate DCF results.
  • User-Friendly Design: Simple structure and clear instructions for all experience levels.

Key Features

  • Comprehensive DCF Calculator: Offers detailed unlevered and levered DCF valuation models tailored for PDS Biotechnology Corporation (PDSB).
  • WACC Calculator: Features a pre-built Weighted Average Cost of Capital sheet with adjustable inputs for accurate assessments.
  • Customizable Forecast Assumptions: Easily modify growth rates, capital expenditures, and discount rates to fit your analysis.
  • Integrated Financial Ratios: Evaluate profitability, leverage, and efficiency ratios specifically for PDS Biotechnology Corporation (PDSB).
  • Interactive Dashboard and Charts: Visual representations present key valuation metrics for straightforward analysis.

How It Works

  • Download: Obtain the pre-formatted Excel file containing PDS Biotechnology Corporation's (PDSB) financial data.
  • Customize: Modify projections, including revenue growth, EBITDA %, and WACC to fit your analysis.
  • Update Automatically: The intrinsic value and NPV calculations refresh in real-time as you make changes.
  • Test Scenarios: Develop various projections and instantly compare the results.
  • Make Decisions: Leverage the valuation findings to inform your investment choices.

Why Choose This Calculator for PDS Biotechnology Corporation (PDSB)?

  • Accurate Data: Up-to-date financial information for PDSB ensures trustworthy valuation outcomes.
  • Customizable: Tailor essential metrics like growth rates, WACC, and tax rates to align with your forecasts.
  • Time-Saving: Pre-configured calculations save you the hassle of starting from the ground up.
  • Professional-Grade Tool: Crafted specifically for investors, analysts, and consultants in the biotech sector.
  • User-Friendly: Easy-to-navigate design and comprehensive instructions cater to users of all experience levels.

Who Should Use This Product?

  • Investors: Accurately assess PDS Biotechnology Corporation’s (PDSB) fair value before making investment choices.
  • CFOs: Utilize a professional-grade DCF model for financial reporting and analysis specific to PDSB.
  • Consultants: Easily customize the template for valuation reports tailored to PDSB clients.
  • Entrepreneurs: Acquire insights into financial modeling practices employed by leading biotech firms.
  • Educators: Implement it as a teaching resource to illustrate valuation methodologies relevant to the biotech sector.

What the Template Contains

  • Preloaded PDSB Data: Historical and projected financial data, including revenue, EBIT, and capital expenditures.
  • DCF and WACC Models: Professional-grade sheets for calculating intrinsic value and Weighted Average Cost of Capital.
  • Editable Inputs: Yellow-highlighted cells for adjusting revenue growth, tax rates, and discount rates.
  • Financial Statements: Comprehensive annual and quarterly financials for deeper analysis.
  • Key Ratios: Profitability, leverage, and efficiency ratios to evaluate performance.
  • Dashboard and Charts: Visual summaries of valuation outcomes and assumptions.